Home » Topics » BioWorld

BioWorld
RSS

AMYLIN FILES SILENT IPO

Dec. 3, 1991

GENE DELIVERY WITHOUT RETROVIRUSES

Dec. 3, 1991

EARLY TRIGGER OF ARTHRITIS TARGETED

Dec. 3, 1991

BILL PROPOSES ORPHAN DRUG LIMITS

Dec. 2, 1991

APPOINTMENTS AND ADVANCEMENTS

Dec. 2, 1991

CENTOCOR FILES FOR OFFERING FOR TOCOR II

Dec. 2, 1991

GENSIA SPINOFF RAISES $50 MILLION IN IPO

Dec. 2, 1991

GENESIS BUYS INTO DRUG DESIGN TECHNOLOGY

Dec. 2, 1991

CHIRON, CETUS SET EXCHANGE RATIO

Nov. 27, 1991

FDA APPROVES HIV ANTIBODY REAGENT

Nov. 27, 1991

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...